Skip to main content
SpringerLink
Log in

Treatment of gram-negative bacillary septicemia with cefoperazone

  • Original Articles
  • Published:
European Journal of Clinical Microbiology Aims and scope Submit manuscript

Abstract

Cefoperazone, a new broad-spectrum cephalosporin, was administered by continuous infusion or intermittent injection to 20 and 25 patients respectively with gram-negative bacillary septicemia most of whom had severe underlying disease. No difference was observed in the clinical response of the two groups. The overall rate of favourable response was 76 %. Of the 40 non-neutropenic patients treated three died of infection despite sensitivity of the organism, three improved temporarily and three died as the result of superinfection. Three of the five neutropenic patients treated failed to respond to cefoperazone therapy, despite adequate serum bactericidal activity. Tolerance to cefoperazone was satisfactory. Emergence of cefoperazone-resistant strains leading to relapse or superinfection was not a major cause of failure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. EORTC International Antimicrobial Therapy Project Group: Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. Journal of Infectious Diseases 1978, 137: 14–29.

    Google Scholar 

  2. Klastersky, J., Zinner, S. H.: Synergistic combinations of antibiotics in gram-negative bacillary infections. Reviews of Infectious Diseases 1982, 4: 294–301.

    PubMed  Google Scholar 

  3. Kay, D., Kobasa, W., Kaye, K.: Susceptibility of anaerobic bacteria to cefoperazone and other antibiotics. Antimicrobial Agents and Chemotherapy 1980, 17: 957–960.

    PubMed  Google Scholar 

  4. Maksymiuk, A. W., Le Blanc, B. M., Brown, N. S., Ho, D. H., Bodey, G. P.: Pharmacokinetics of cefoperazone in patients with neoplastic disease. Antimicrobial Agents and Chemotherapy 1981, 19: 1037–1041.

    PubMed  Google Scholar 

  5. Feld, R., Tuffnell, P. G., Curtis, J. E., Messner, H. A., Hasselback, R.: Empiric therapy for infections in granulocytopenic cancer patients. Continuous infusion of amikacin plus cephalothin. Archives of Internal Medicine 1979, 139: 310–314.

    PubMed  Google Scholar 

  6. Keating, M. J., Bodey, G. P., Valdivieso, M., Rodriguez, V.: A randomized comparative trial of three aminoglycosides. Comparison of continuous infusions of gentamicin, amikacin and sisomicin combined with carbenicillin in the treatment of infections in neutropenic patients with malignancies. Medicine 1979, 58: 159–170.

    PubMed  Google Scholar 

  7. Bodey, G. P., Ketchel, S. J., Rodriguez, V.: A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patients. American Journal of Medicine 1979, 67: 608–616.

    PubMed  Google Scholar 

  8. Bennett, J. V., Brodie, J. L., Benner, E. J., Kirby, W. M. M.: Simplified accurate method for antibiotic assay of clinical specimens. Applied Microbiology 1965, 14: 170–177.

    Google Scholar 

  9. Reller, L. B., Stratton, C. W.: Serum dilution test for bactericidal activity. II. Standardization and correlation with antimicrobial assays and susceptibility tests. Journal of Infectious Diseases 1977, 130: 454–463.

    Google Scholar 

  10. Klastersky, J., Daneau, D., Swings, G., Weerts, D.: Antibacterial activity in serum and urine as a therapeutic guide in bacterial infections. Journal of Infectious Diseases 1974, 129: 187–193.

    PubMed  Google Scholar 

  11. Platt, R., Ehlich, S. L., Afarian, J., O'Brien, T. F., Pennington, J. E., Kass, E. H.: Moxalactam therapy of infections caused by cephaloth-inresistant bacteria: influence of serum inhibitory activity on clinical response and acquisition of antibiotic resistance during therapy. Antimicrobial Agents and Chemotherapy 1981, 20: 351–355.

    PubMed  Google Scholar 

  12. Van Laethem, Y., Lagast, H., Klastersky, J.: Serum bactericidal activity of ceftazidime and cefoperazone alone or in combination with amikacin againstPseudomonas aeruginosa andKlebsiella pneumoniae. Antimicrobial Agents and Chemotherapy 1983, 23: 435–439.

    PubMed  Google Scholar 

  13. Gerber, A. V., Craig, W. A.: Growth kinetics of respiratory pathogens after short exposures to ampicillin and erythromycin in vitro. Journal of Antimicrobial Chemotherapy 1981, 8, Supplement C: 81–91.

    Google Scholar 

  14. Wilson, D. A., Robinson, G. N.: The recovery period following exposure of bacteria to penicillin. Chemotherapy 1979, 25: 14–22.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service de Médecine Interne et Laboratoire d'Investigation Clinique, Institut Jules Bordet, Centre des Tumeurs de l'Université Libre de Bruxelles, 1, rue Héger-Bordet, 1000, Bruxelles, Belgium

    H. Lagast, F. Meunier-Carpentier & J. Klastersky

Authors
  1. H. Lagast
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Meunier-Carpentier
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Klastersky
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lagast, H., Meunier-Carpentier, F. & Klastersky, J. Treatment of gram-negative bacillary septicemia with cefoperazone. Eur. J, Clin. Microbiol. 2, 554–558 (1983). https://doi.org/10.1007/BF02016564

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02016564

Keywords

Search

Navigation